Our New Innovation – Black Pearl Technology. Inherit from Autologous Conditioned Serum (ACS). “In RCT, our dream is to overcome global medical challenges with innate human potentials and our innovation, Black Pearl Technology.” Five years of Clinical and Laboratory research treating more than 1000 patients, WIPO patent for Black Pearl Technology
